CR11836A - Prueba de diagnostico inmediato para la deteccion de exposicion o inmunidad contra el virus del dengue - Google Patents

Prueba de diagnostico inmediato para la deteccion de exposicion o inmunidad contra el virus del dengue

Info

Publication number
CR11836A
CR11836A CR11836A CR11836A CR11836A CR 11836 A CR11836 A CR 11836A CR 11836 A CR11836 A CR 11836A CR 11836 A CR11836 A CR 11836A CR 11836 A CR11836 A CR 11836A
Authority
CR
Costa Rica
Prior art keywords
dengue virus
diagnostic test
exposure
immunity against
detection
Prior art date
Application number
CR11836A
Other languages
English (en)
Inventor
Kumar Sil Bijon
yun ying Tan
Original Assignee
Mp Biomedicals Asia Pacific Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mp Biomedicals Asia Pacific Pte Ltd filed Critical Mp Biomedicals Asia Pacific Pte Ltd
Publication of CR11836A publication Critical patent/CR11836A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G01N2333/183—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus
    • G01N2333/185—Flaviviruses or Group B arboviruses, e.g. yellow fever virus, japanese encephalitis, tick-borne encephalitis, dengue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invención provee una "prueba de diagnóstico inmediato" (PDCT) para detectar a un sujeto que ha estado expuesto al virus del dengue o parte inmunológica del mismo o quien ha logrado algún nivel de inmunidad contra un antígeno del virus del dengue.
CR11836A 2008-05-15 2010-12-09 Prueba de diagnostico inmediato para la deteccion de exposicion o inmunidad contra el virus del dengue CR11836A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SG200803904-2A SG157244A1 (en) 2008-05-15 2008-05-15 Point of care test for the detection of exposure or immunity to dengue virus

Publications (1)

Publication Number Publication Date
CR11836A true CR11836A (es) 2011-06-07

Family

ID=41318932

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11836A CR11836A (es) 2008-05-15 2010-12-09 Prueba de diagnostico inmediato para la deteccion de exposicion o inmunidad contra el virus del dengue

Country Status (7)

Country Link
BR (1) BRPI0915291A2 (es)
CO (1) CO6311040A2 (es)
CR (1) CR11836A (es)
EC (1) ECSP10010680A (es)
MX (1) MX2010012363A (es)
SG (1) SG157244A1 (es)
WO (1) WO2009139725A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG165194A1 (en) * 2009-03-20 2010-10-28 Mp Biomedicals Asia Pacific Pte Ltd Point of care test for the detection of exposure to hev immunoglobulin a (iga)
CN102393454A (zh) * 2011-08-24 2012-03-28 中国检验检疫科学研究院 检测登革病毒抗体的胶体金试纸条及其制备方法和应用
CN113637694A (zh) 2013-03-15 2021-11-12 武田疫苗股份有限公司 用于疫苗中的登革热病毒嵌合式构建物的组合物及方法
SG10201404571PA (en) * 2014-08-01 2016-03-30 Mp Biomedicals Asia Pacific Pte Ltd Method and kit for detecting a dengue virus infection
US11464815B2 (en) 2018-09-05 2022-10-11 Takeda Vaccines, Inc. Dengue vaccine unit dose and administration thereof
ES2908304T3 (es) 2018-09-05 2022-04-28 Takeda Vaccines Inc Dosis unitaria de vacuna contra el dengue y administración de la misma
WO2021202992A2 (en) * 2020-04-03 2021-10-07 Lawrence Loomis Rapid point of care assay for the detection of the asymptomatic carrier state of covid-19
WO2021216276A1 (en) * 2020-04-24 2021-10-28 Massachusetts Institute Of Technology Rapid, point of care detection of neutralizing antibodies against a virus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03148066A (ja) * 1989-11-06 1991-06-24 Nippon Zeon Co Ltd ウイルス感染症診断用メンブレンおよび診断方法
JP2001511459A (ja) * 1997-07-31 2001-08-14 ハワイ バイオテクノロジー グループ， インコーポレイテッド フラビウイルス感染に対抗する組換え二量体エンベロープワクチン
FR2767324B1 (fr) * 1997-08-14 2001-04-06 Pasteur Institut Utilisation de proteines d'enveloppe recombinantes pour le diagnostic du virus de la dengue
WO2005014627A1 (en) * 2003-08-07 2005-02-17 International Centre For Genetic Engineering And Biotechnology Recombinant dengue multi epitope proteins as diagnostic intermediates
SG137711A1 (en) * 2006-05-11 2007-12-28 Nat Environment Agency Antigen capture anti-dengue iga elisa (aca-elisa) for the detection of a flavivirus specific antibody

Also Published As

Publication number Publication date
SG157244A1 (en) 2009-12-29
MX2010012363A (es) 2011-04-11
ECSP10010680A (es) 2011-04-29
CO6311040A2 (es) 2011-08-22
BRPI0915291A2 (pt) 2016-02-16
WO2009139725A1 (en) 2009-11-19

Similar Documents

Publication Publication Date Title
CR11836A (es) Prueba de diagnostico inmediato para la deteccion de exposicion o inmunidad contra el virus del dengue
BR112022012891A2 (pt) Instrumento cirúrgico compreendendo sistema de detecção
CO6551725A2 (es) Dispositivo para la identificación de afecciones orales
BR112013033418A2 (pt) método e aparelho para testar infratores no uso de drogas
BR112015022763A8 (pt) sensor para detectar um analito
BR112012030552A2 (pt) composição imunogênica
BR112014013082A2 (pt) método para detectar adutos nucleossomos
CO6160335A2 (es) Vacuna
MX340547B (es) Equipos de prueba de diagnostico.
BR112015023421A2 (pt) método e sistema de inspeção de lâminas de turbinas eólicas com a base no solo
CO6690763A2 (es) Anticuerpo específico de miostatina y composiciones que lo contienen
BR112013023540A2 (pt) anticorpo, kit e método para a determinação de peptídeos amilóides
CO6551750A2 (es) Vacuna del virus del dengue inactivado que incluye un adyuvante sin aluminio
EP2078083A4 (en) NEW DOG INFLUENZA VIRUS AND VEGETABLE THEREFOR
BR112013001060A2 (pt) dispositivo de detecção
BR112013020743A2 (pt) composições e métodos para a terapia e diagnóstico de influenza
BR112015001414A2 (pt) composição antideriva
CY1123265T1 (el) Μια αναλυση κυτταρικως μεσολαβουμενης ανοσοαποκρισhς
CY1115437T1 (el) Υδροξυμεθυλοκυκλοεξυλαμινες
DK2396652T3 (da) Diagnose af inflammatorisk tarmsyndrom baseret på cytoletalt udspilende toksin
CY1116083T1 (el) Μεθοδος για τον εντοπισμο τυπων του ιου των ανθρωπινων θηλωματων (hpv)
CL2011003043A1 (es) Composicion para proteger sujeto contra serotipo de virus del dengue que comprende al menos dos serotipos de virus dengue; sistema para administrar una composicion de vacuna del dengue; kit de vacuna porque comprende al menos una composicion de vacuna contra el virus del dengue.
WO2012039622A8 (en) An apparatus and method for inspecting matter
BR112014009223A2 (pt) método para o diagnóstico da doença de niemann-pick
BR112015031197A2 (pt) sistema de medida de pressão discriminando uma pane de uma superpressão ou de depressão

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)